CTRI/2019/03/018291已完成3 期
Rivastigmine for Cognitive Impairment in Multiple Sclerosis : A Parallel Group Randomised Open Label study with Blinded End point Assessment
AMRITA GOTUR0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Written informed consent to participate in the trial.
- •2. Males and Females between 18 yrs and 65 yrs of age
- •3. Definite diagnosis of Multiple Sclerosis as defined by 2017 Revised Mc Donald Criteria
- •4. Sufficient education to read, write and communicate comprehensibly.
排除标准
- •-Relapse in the recent 2 months
- •-Presence of systemic disease affecting cognition ( stroke, head trauma, PD),
- •-Presence of neuropsychiatric conditions affecting cognition ( major depression ),
- •-Those who refuse consent
- •-Pregnant and lactating women
研究者
相似试验
招募中
不适用
Effects of rivastigmine on cognitive function and appetite.s diseaseAlzheimer's diseaseJPRN-UMIN000041148Second Department of Internal Medicine, Faculty of Medical Scieces, University of Fukui
招募中
3 期
Effectiveness of Rivastigmine and Donepezil on cognitive disordersIRCT20210819052232N1Esfahan University of Medical Sciences165
已完成
2 期
Efficacy of rivastigmin in the treatment of major depressive disorderIRCT2017020132236N4Vice chancellor for research, Mazandaran University of Medical Sciences20
招募中
3 期
Evaluation of the effect of rivastigmine on male patients with chronic schizophreniaIRCT20120314009297N8Mazandaran University of Medical Sciences60
已完成
2 期
The effectiveness of Rivastigmine on treatment of Tardive dyskinesiaTardive dyskinesia.Drug-induced dystoniaIRCT2012092910964N1niversity of Social Welfare and Rehabilitation Sciences40